Accelerating Australia turns leader to transform biomedical expertise
Category: #health  By Saipriya Iyer  Date: 2018-04-13
  • share
  • Twitter
  • Facebook
  • LinkedIn

Accelerating Australia turns leader to transform biomedical expertise

Accelerating Australia, a Biomedical Innovation Group based in Western Australia, has received funds from a consortium of firms for financing its training & medical Biodesign programs. The move is likely to promote partnerships and innovations across myriad pharmaceuticals as well as medical sectors.

For the record, Accelerating Australia came into existence in October in 2017 through an investment of nearly USD 1 million in the form of federal grants. Since then it has received funds from Monash University, Avita Medical, Centre for Entrepreneurial Research and Innovation in Perth, Harry Perkins Institute of Medical Research, St. John of God Healthcare, University of Adelaide, and the University of Sydney.

Experts are of the view that the West Australian group is rapidly emerging as a dominant force across the Australian Biomedical sector through the introduction of innovative therapies and healthcare expertise. A biomedical researcher at Harry Perkins, Kevin Pfleger was quoted stating that the consortium members have put away their differences and business rivalries to financially support Accelerating Australia.

With the new investments, the WA based firm will enter into a collaboration with Spark Co-Lab in the Stanford University located medical innovation project, launched by Spark nearly two years back. Recently, the course has been renamed as Perth Biodesign and is rolled out across the country with its initial launch in Adelaide. The course integrates teams from medical, science, and engineering background for developing new medical equipment to fulfill the unmet medical needs of the patients.  

For the record, Accelerating Australia has registered outstanding results via its training courses that includes brokering multidisciplinary associations, offering commercialization advise, and increasing awareness about biomedical commercial activities.

Participants of the training course have achieved tremendous progress that has made them acquire new technological landmarks. The breakthroughs made by the firms include identification of early phase infections of orthopaedic implants, which is allegedly the focus of Biacor Pty Ltd, spin-out of SPARK Co-Lab Design project.



About Author

Saipriya Iyer

Email: [email protected]   

Saipriya Iyer

Saipriya Iyer develops content for Market Size Forecasters, Algosonline, and myriad other platforms. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her bel...

Read More

More News By Saipriya Iyer

DTE Energy pledges to reach net-zero emissions of GHG by 2050
DTE Energy pledges to reach net-zero emissions of GHG by 2050
By Saipriya Iyer

DTE Energy has reportedly pledged to reach the net-zero GHG (greenhouse gas) emissions by 2050. This can be ensured through various actions involving customers, suppliers, and its infrastructure, that align with the lo...

Researchers investigate a novel treatment for Childhood Alzheimer’s
Researchers investigate a novel treatment for Childhood Alzheimer’s
By Saipriya Iyer

Researchers at the Lundquist Institute have reportedly collaborated with the Cure Sanfilippo Foundation on a new clinical trial to investigate if repurposing an anti-inflammatory drug could provide relief to children t...

Amazon unveils $2 billion climate fund to help decarbonize economies
Amazon unveils $2 billion climate fund to help decarbonize economies
By Saipriya Iyer

Amazon, the renowned technology and online retail giant, has reportedly announced a new initiative that would help efforts to develop sustainable technologies, products, and services that would allow Amazon and several...